Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023 Apr 18, 2023 11:00 HKT |  |
|
Endurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in China Apr 17, 2023 22:29 HKT |  |
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies Apr 17, 2023 19:30 HKT |  |
|
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore Apr 14, 2023 17:18 HKT |  |
|
Responding to the Need for Accelerated Nursing Credentials Verification, CGFNS and NCSBN Step Up Collaboration to Address Gaps and Improve Efficiencies Apr 12, 2023 19:30 HKT |  |
|
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China Apr 11, 2023 12:58 HKT |  |
|
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50% Apr 11, 2023 08:00 HKT |  |
|
Life Science Incubator Signs MOU with a strategic anchor tenant for its planned Brisbane Co-Working Laboratory Space Project Apr 06, 2023 14:00 HKT |  |
|
Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product Apr 05, 2023 18:00 HKT |  |
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies Apr 04, 2023 17:00 HKT |  |
|
Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022 Apr 03, 2023 14:52 HKT |  |
|
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition Apr 03, 2023 12:00 HKT |  |
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results Mar 31, 2023 21:11 HKT |  |
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator Mar 31, 2023 20:15 HKT |  |
|
Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia Mar 31, 2023 09:28 HKT | |
|
Ocumension Therapeutics Announces 2022 Annual Results Mar 30, 2023 22:29 HKT |  |
|
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq Mar 30, 2023 20:29 HKT |  |
|
Universal Medical (2666.HK) Announces 2022 Annual Results Mar 29, 2023 19:35 HKT |  |
|
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter Mar 28, 2023 20:00 HKT |  |
|
Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting Mar 28, 2023 19:00 HKT |  |
|